Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Summarizing we provide a detailed characterization of the interaction of p53 with FOXO4 and FOXO4-DRI which is the basis for development of p53 inhibitors to treat diseases linked to cellular senescence such as cancers
Additionally, B-CQDs administered intravenously localised in kidneys and lymph nodes, intraperitoneally in intestines, liver, heart, and spinal cord, and orally in liver, kidneys, and lymphatic tissue, with peak tissue accumulation occurring at 30 min, and rapid systemic clearance within 2 hours [159]
Track your wins
Jin J, Kang HM, Jung J, Jeong JW, Park C
US$ 28.72
US$ 22.88
US$ 25.24
US$ 26.92
US$ 20.22
US$ 26.64
